Guk-Jin Son

Guk-Jin Son currently serves as the CEO and Korea Representative for AnaPath Services & AnaPath Research S.A.U. since November 2020. Prior to this role, Guk-Jin held the position of Head of Business Development at Ginapath, Co., Ltd from October 2014 to September 2020, where responsibilities included supporting new drug and biosimilar development, overseeing contract manufacturing and research, and consulting on drug development processes. Guk-Jin's career also includes experience as the Manager of Business Development at CMIC Korea and Harlan Laboratories, where a focus on new drug development, non-clinical and clinical studies, and strategic consulting for drug development was emphasized.